Mirae Asset Global Investments
PTGX icon

Mirae Asset Global Investments’s Protagonist Therapeutics PTGX Stock Holding History

Mirae Asset Global Investments’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$353K Sell
2,876
-452
-14% -$47.2K ﹤0.01% 1036
2026
Q1 		$351K Buy
3,328
+290
+10% +$25.7K ﹤0.01% 998
2025
Q4 		$265K Buy
3,038
+633
+26% +$51.8K ﹤0.01% 1104
2025
Q3 		$160K Buy
2,405
+11
+0.5% +$625 ﹤0.01% 1148
2025
Q2 		$132K Buy
2,394
+340
+17% +$16.3K ﹤0.01% 1099
2025
Q1 		$100K Buy
2,054
+68
+3% +$2.85K ﹤0.01% 1129
2024
Q4 		$77.4K Sell
1,986
-144
-7% -$6.28K ﹤0.01% 1194
2024
Q3 		$94.9K Buy
2,130
+379
+22% +$15.3K ﹤0.01% 1188
2024
Q2 		$55.8K Sell
1,751
-27,807
-94% -$814K ﹤0.01% 1228
2024
Q1 		$692K Sell
29,558
-2,201
-7% -$59.9K ﹤0.01% 1736
2023
Q4 		$728K Sell
31,759
-5,463
-15% -$95.6K ﹤0.01% 1786
2023
Q3 		$621K Buy
37,222
+1,555
+4% +$30.2K ﹤0.01% 1778
2023
Q2 		$986K Buy
35,667
+8,038
+29% +$201K ﹤0.01% 1576
2023
Q1 		$635K Buy
27,629
+7,752
+39% +$130K ﹤0.01% 1813
2022
Q4 		$217K Buy
19,877
+20
+0.1% +$169 ﹤0.01% 2275
2022
Q3 		$167K Buy
19,857
+5,934
+43% +$56.2K ﹤0.01% 2395
2022
Q2 		$110K Buy
+13,923
New +$168K ﹤0.01% 2292

Other funds holding PTGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM

Mirae Asset Global Investments's PTGX Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Protagonist Therapeutics (PTGX) stake by 14% in Q2 2026, selling an estimated $47.2K and leaving 2,876 shares worth $353K. The position accounts for ﹤0.01% of the portfolio, ranked #1036.

Mirae Asset Global Investments first reported a position in PTGX in Q2 2022 and has held it in 17 quarters since. The position peaked at $986K in Q2 2023. 142 funds tracked by Wall St. Rank hold PTGX as of Q2 2026.

  • Mirae Asset Global Investments held 2,876 shares of Protagonist Therapeutics worth $353K as of Q2 2026.
  • Mirae Asset Global Investments sold 452 Protagonist Therapeutics shares in Q2 2026, an estimated $47.2K.
  • Protagonist Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1036 holding.
  • Mirae Asset Global Investments first reported a position in Protagonist Therapeutics in Q2 2022 and has held it in 17 quarters since.
  • Mirae Asset Global Investments's Protagonist Therapeutics position peaked at $986K in Q2 2023.
  • 142 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.